Dapsone 25 MG Oral Tablet — RxCUI 197558
RxNorm drug concept · Semantic clinical drug
RxCUI 197558
Semantic clinical drug · SCD
● Current RxNorm concept 27 FDA products
59 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197558
Official nameDapsone 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped27
Package NDCs mapped59
Reported Medicaid activity (SDUD)18,040 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dapsone Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Aczone gel is a prescription topical treatment for acne vulgaris — the kind of acne that causes pimples, blackheads, and inflamed spots on the face, chest, back, and shoulders. It'...
- Start with clean, dry skin — gently wash the area and pat it dry. Then squeeze out about a pea-sized amount of gel and spread a thin layer over the acne-affected areas. Rub it in g...
- Possibly, yes — this is a real, known interaction. If you apply benzoyl peroxide after dapsone gel, some people do get a temporary yellow or orange tint on their skin or facial hai...
- Will it turn my skin yellow if I also use benzoyl peroxide?
🕸️ Concept Web — How Dapsone 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dapsone 25 MG Oral Tablet
RxCUI 197558 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dapsone
3108IN
-
Dapsone
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dapsone Oral Tablet
371689SCDF -
Dapsone Oral Product
1151858SCDG -
Dapsone Pill
1151859SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Dapsone Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dapsone 25 MG
315760SCDC
-
Dapsone 25 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dapsone 25 MG
SCDC · 315760 -
Dapsone Oral Tablet
SCDF · 371689 -
Dapsone Oral Product
SCDG · 1151858 -
Dapsone Pill
SCDG · 1151859
📦 FDA Products & Package NDCs
27 products · 59 package NDCs
59 package NDCs map to RxCUI 197558 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13925-0504-01 | 100 TABLET in 1 BOTTLE (13925-504-01) | Dapsone | Seton Pharmaceuticals | 2016-03-10 |
| 13925-0505-01 | 100 TABLET in 1 BOTTLE (13925-505-01) | Dapsone | Seton Pharmaceuticals | 2016-03-10 |
| 42291-0008-01 | 100 TABLET in 1 BOTTLE (42291-008-01) | Dapsone | AvKARE | 2024-03-06 |
| 51672-4197-06 | 30 TABLET in 1 BOTTLE (51672-4197-6) | Dapsone | Sun Pharmaceutical Industries, Inc. | 2019-03-01 |
| 51672-4198-06 | 30 TABLET in 1 BOTTLE (51672-4198-6) | Dapsone | Sun Pharmaceutical Industries, Inc. | 2019-03-01 |
| 60429-0495-30 | 30 TABLET in 1 BOTTLE (60429-495-30) | Dapsone | Golden State Medical Supply, Inc. | 2016-05-09 |
| 62135-0965-30 | 30 TABLET in 1 BOTTLE (62135-965-30) | Dapsone | Chartwell RX, LLC | 2025-04-08 |
| 62135-0966-30 | 30 TABLET in 1 BOTTLE (62135-966-30) | Dapsone | Chartwell RX, LLC | 2025-04-08 |
| 64980-0566-01 | 100 TABLET in 1 BOTTLE (64980-566-01) | Dapsone | Rising Pharma Holdings, Inc. | 2022-12-11 |
| 64980-0566-03 | 30 TABLET in 1 BOTTLE (64980-566-03) | Dapsone | Rising Pharma Holdings, Inc. | 2023-07-12 |
| 64980-0567-01 | 100 TABLET in 1 BOTTLE (64980-567-01) | Dapsone | Rising Pharma Holdings, Inc. | 2023-07-20 |
| 64980-0567-03 | 30 TABLET in 1 BOTTLE (64980-567-03) | Dapsone | Rising Pharma Holdings, Inc. | 2023-08-29 |
| 69367-0378-01 | 100 TABLET in 1 BOTTLE (69367-378-01) | Dapsone | Westminster Pharmaceuticals, LLC | 2024-01-16 |
| 69367-0378-30 | 30 TABLET in 1 BOTTLE (69367-378-30) | Dapsone | Westminster Pharmaceuticals, LLC | 2024-01-16 |
| 69367-0379-01 | 100 TABLET in 1 BOTTLE (69367-379-01) | Dapsone | Westminster Pharmaceuticals, LLC | 2024-01-16 |
| 69367-0379-30 | 30 TABLET in 1 BOTTLE (69367-379-30) | Dapsone | Westminster Pharmaceuticals, LLC | 2024-01-16 |
| 69367-0409-01 | 100 TABLET in 1 BOTTLE (69367-409-01) | Dapsone | Westminster Pharmaceuticals, LLC | 2025-08-21 |
| 69367-0409-30 | 30 TABLET in 1 BOTTLE (69367-409-30) | Dapsone | Westminster Pharmaceuticals, LLC | 2025-08-21 |
| 69367-0410-01 | 100 TABLET in 1 BOTTLE (69367-410-01) | Dapsone | Westminster Pharmaceuticals, LLC | 2025-08-21 |
| 69367-0410-30 | 30 TABLET in 1 BOTTLE (69367-410-30) | Dapsone | Westminster Pharmaceuticals, LLC | 2025-08-21 |
| 70771-1979-01 | 100 TABLET in 1 BOTTLE (70771-1979-1) | Dapsone | Zydus Lifesciences Limited | 2026-02-27 |
| 70771-1979-03 | 30 TABLET in 1 BOTTLE (70771-1979-3) | Dapsone | Zydus Lifesciences Limited | 2026-02-27 |
| 70771-1980-01 | 100 TABLET in 1 BOTTLE (70771-1980-1) | Dapsone | Zydus Lifesciences Limited | 2026-02-27 |
| 70771-1980-03 | 30 TABLET in 1 BOTTLE (70771-1980-3) | Dapsone | Zydus Lifesciences Limited | 2026-02-27 |
| 70954-0135-10 | 30 TABLET in 1 BOTTLE (70954-135-10) | DAPSONE | ANI Pharmaceuticals, Inc. | 2018-01-15 |
| 70954-0135-20 | 100 TABLET in 1 BOTTLE (70954-135-20) | DAPSONE | ANI Pharmaceuticals, Inc. | 2018-01-15 |
| 70954-0136-10 | 30 TABLET in 1 BOTTLE (70954-136-10) | DAPSONE | ANI Pharmaceuticals, Inc. | 2018-01-15 |
| 70954-0136-20 | 100 TABLET in 1 BOTTLE (70954-136-20) | DAPSONE | ANI Pharmaceuticals, Inc. | 2018-01-15 |
| 72578-0177-01 | 100 TABLET in 1 BOTTLE (72578-177-01) | Dapsone | Viona Pharmaceuticals Inc | 2026-02-27 |
| 72578-0177-06 | 30 TABLET in 1 BOTTLE (72578-177-06) | Dapsone | Viona Pharmaceuticals Inc | 2026-02-27 |
| 72578-0178-01 | 100 TABLET in 1 BOTTLE (72578-178-01) | Dapsone | Viona Pharmaceuticals Inc | 2026-02-27 |
| 72578-0178-06 | 30 TABLET in 1 BOTTLE (72578-178-06) | Dapsone | Viona Pharmaceuticals Inc | 2026-02-27 |
| 73190-0037-01 | 100 TABLET in 1 BOTTLE (73190-037-01) | Dapsone | AvKARE | 2025-12-10 |
| 82804-0988-00 | 100 TABLET in 1 BOTTLE (82804-988-00) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-11 | 1000 TABLET in 1 BOTTLE (82804-988-11) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-30 | 30 TABLET in 1 BOTTLE (82804-988-30) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-55 | 500 TABLET in 1 BOTTLE (82804-988-55) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-60 | 60 TABLET in 1 BOTTLE (82804-988-60) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-64 | 240 TABLET in 1 BOTTLE (82804-988-64) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-72 | 120 TABLET in 1 BOTTLE (82804-988-72) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-78 | 180 TABLET in 1 BOTTLE (82804-988-78) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0988-90 | 90 TABLET in 1 BOTTLE (82804-988-90) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-00 | 100 TABLET in 1 BOTTLE (82804-989-00) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-11 | 1000 TABLET in 1 BOTTLE (82804-989-11) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-30 | 30 TABLET in 1 BOTTLE (82804-989-30) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-55 | 500 TABLET in 1 BOTTLE (82804-989-55) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-60 | 60 TABLET in 1 BOTTLE (82804-989-60) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-64 | 240 TABLET in 1 BOTTLE (82804-989-64) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-72 | 120 TABLET in 1 BOTTLE (82804-989-72) | Dapsone | Proficient Rx LP | 2024-05-21 |
| 82804-0989-78 | 180 TABLET in 1 BOTTLE (82804-989-78) | Dapsone | Proficient Rx LP | 2024-05-21 |
Observed labelers:
Proficient Rx LP (18) ·
Westminster Pharmaceuticals, LLC (8) ·
ANI Pharmaceuticals, Inc. (4) ·
Everest Life Sciences. LLC (4) ·
Rising Pharma Holdings, Inc. (4) ·
Solis Pharmaceuticals Inc. (4)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.